BOC Sciences is committed to the development of cutting-edge PEGylation technology. We have established a full or partial technology development service including mature PEGylation process, purification process, determination of quality standards and key process parameters, and subsequent formulation development of products. BOC Sciences provides PEG conjugated Antibodies service to customers worldwide to promote your research.
Although antibody technology has developed rapidly, antibody drugs are limited in their use because natural or recombinant unmodified antibodies are prone to cause an immune response in the body. PEG modification can overcome the short half-life of antibody fragments in blood circulation, reduce the cost of antibody fragments, and make them useful for clinical treatment.
The immunogenicity of PEG conjugated antibodies is significantly reduced, solubility, stability is enhanced, and bioavailability is improved, while retaining its biological activity to the maximum. Compared with the prototype drug, PEG-modified antibody has reduced toxicity, and other chemical and biological properties have not changed.
BOC Sciences provides customers with PEG conjugated antibodies services. Below is a list of our available PEG conjugated antibodies Services (include but not limited to the following):
- Exploration and establishment of antibody PEGylation process
- Process development and optimization of PEG conjugated antibodies drug production
- Development of drug analysis methods for PEGylation antibodies
- Process development of PEG conjugated antibodies manufacturing
- Strong background and expertise in modern chemistry
- Innovative and novel PEG technology, and advanced equipment
- Ensure fast, efficient and optimized PEG conjugated Antibodies
- Analytical HPLC and MS analyses are performed in every development cycle.
- Cost-effective and high-quality products.